Acquiring Company
Keen Vision Acquisition Corporation
Acquired Company
Medera
Summit
UtrechtBiotechnologyAgriculture and FarmingVenture CapitalBiotechnologyTherapeuticsBiopharmaDescription
Keen Vision Acquisition Corp. has entered into a merger agreement with Medera Inc., a clinical stage biopharmaceutical company. This merger aims to form a new entity in the Cayman Islands, focusing on stem cell-based therapies. Keen Vision has extended its timeline to finalize the merger until May 27, 2025. The partnership signifies a commitment to advancing innovative biopharmaceutical technologies.
Quick answer
Keen Vision Acquisition Corporation is acquiring Medera, announced May 14, 2025. Keen Vision Acquisition Corporation is based in Summit, New Jersey, United States.
- How much did Keen Vision Acquisition Corporation pay for Medera?
- The deal value was not disclosed.
- What does Keen Vision Acquisition Corporation do?
- Keen Vision Acquisition Corporation is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative growth companies.
- Where are Keen Vision Acquisition Corporation and Medera based?
- Keen Vision Acquisition Corporation is based in Summit, New Jersey, United States. Medera is based in Utrecht, Utrecht, Netherlands.
Source: Fundz verified event record.
Other recent acquisitions in Agriculture and Farming and Venture Capital
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Cerevel Therapeutics for $45 per share (May 28, 2025)
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
- AbbVie acquires Cerevel Therapeutics for $45 per share (March 31, 2025)
- Exicure, Inc. acquires GPCR USA for cancer therapy expansion (June 27, 2025)
- OS Therapies completes acquisition of Advaxis assets from Ayala Pharmaceuticals (April 12, 2025)
- Concentra to acquire Elevation Oncology, shut it down (June 20, 2025)
Who to call at Keen Vision Acquisition Corporation, and when
When Keen Vision Acquisition Corporation changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Keen Vision Acquisition Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Keen Vision Acquisition Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Keen Vision Acquisition Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Keen Vision Acquisition Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Medera?
Medera was acquired by Keen Vision Acquisition Corporation, based in Summit. The deal was reported on May 14, 2025. Keen Vision Acquisition Corporation is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative growth companies. Keen Vision Acquisition Corporation is publicly traded (KVACF) and operates in Biotechnology.
When did Keen Vision Acquisition Corporation acquire Medera?
Keen Vision Acquisition Corporation's acquisition of Medera was reported on May 14, 2025. Keen Vision Acquisition Corp. has entered into a merger agreement with Medera Inc., a clinical stage biopharmaceutical company. This merger aims to form a new entity in the Cayman Islands, focusing on stem cell-based therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Medera do?
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat or currently incurable diseases with significant unmet needs. It is privately held, operating in Biotechnology, and is based in Utrecht.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.